Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Board of Directors

Board of DirectorsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Rajesh C. Shrotriya, MD
Chairman, Chief Executive Officer and President
Raymond W. Cohen
Stuart M. Krassner, ScD, PsyD
Luigi Lenaz MD
Anthony E. Maida III, PhD, MA, MBA
Gilles Gagnon M.Sc., MBA, ICD
Dolatrai M. Vyas PhD

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
6.88
Change:
+ 0.18
Day High:
6.95
Day Low:
6.70
Volume:
445,800
4:00 PM ET on Apr 16, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company